Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Article - 04/02/2013 08265_de.jpg

    SYGNIS Pharma - the "new" one: development and commercialisation of molecular diagnostics products

    Heidelberg-based SYGNIS Pharma AG is to discontinue its therapeutic R&D projects targeting human nervous system diseases and will in future focus on the research and development of novel molecular biology technologies, including DNA amplification and sequencing as well as drug screening.

    https://www.gesundheitsindustrie-bw.de/en/article/news/sygnis-pharma-the-new-one-development-and-commercialisation-of-molecular-diagnostics-products
  • Funding

    2022 Research Grants – AI for predictive diagnostics & therapeutic target discovery

    Funding programme, Funded by: Merck KGaA, Submission deadline: 31/08/2022
    https://www.gesundheitsindustrie-bw.de/en/database/funding/2022-research-grants-ai-predictive-diagnostics-therapeutic-target-discovery
  • Article - 11/08/2014 Photo showing a real-time PCR system in the laboratory.

    dsl-Labor: developing PCR tests for medical diagnostics

    PCR has become a common application in medical diagnostics, in areas ranging from the detection of microbes to genetic testing. The demand for new tests is huge, given that there is a seemingly endless list of applications for which PCR can be used. dsl-Labor für Molekulargenetische Diagnostik specialises in the development of PCR tests and also gives advice and training to medical laboratory personnel. Veterinarians are among the company’s major…

    https://www.gesundheitsindustrie-bw.de/en/article/news/dsl-labor-developing-pcr-tests-for-medical-diagnostics
  • Microfluidic systems - 18/11/2021 Hand holding a round plastic disk with numerous channels and chambers.

    Dermagnostix develops molecular diagnostic tests for skin diseases

    Dermagnostix GmbH has developed a rapid test to differentiate between psoriasis and eczema. This test is currently undergoing preclinical testing, with market launch planned for 2023. The start-up is already working on two other dermatological tests. Centrifugal microfluidics is the name of the technology on which the tests are based.

    https://www.gesundheitsindustrie-bw.de/en/article/news/dermagnostix-develops-molecular-diagnostic-tests-skin-diseases
  • Article - 30/08/2010 12175_de.jpg

    A centre focusing on hepatocellular carcinoma research

    Under its director, Prof. Dr. Peter Schirmacher, the Institute of Pathology at the University of Heidelberg has become a major liver cancer research centre, with a particular focus on hepatocellular carcinoma. The institute is looking for new diagnostic markers and new molecular targets for drugs that have the potential to be used for specifically treating this cancer.

    https://www.gesundheitsindustrie-bw.de/en/article/news/a-centre-focusing-on-hepatocellular-carcinoma-research
  • Press release - 27/04/2020

    EIT Health pledges €6m funding to accelerate COVID-19 solutions

    EIT Health has announced over €6m of funding in the fight against COVID-19. The funding will be dedicated to 14 specially selected health innovation projects across Europe which will focus on immediate and impactful solutions that can be found to arm health services with better tools in navigating the pandemic.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/eit-health-pledges-eur6m-funding-accelerate-covid-19-solutions
  • Press release - 22/11/2012 18767_de.jpg

    CeGaT and Genomatix are finalists of Boston Children’s Hospital’s CLARITY challenge

    CeGaT (Center for Genomics and Transcriptomics) GmbH, the Department of Prostate Cancer Research, Institute of Pathology, University Hospital Bonn and Genomatix Software GmbH were announced as finalist (Top 3) of the CLARITY challenge, organized by Boston Children’s Hospital.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/cegat-and-genomatix-are-finalists-of-boston-children-s-hospital-s-clarity-challenge
  • Press release - 18/01/2010 The photo shows the new screening method involving an automated Raman spectroscope developed by the Fraunhofer IPM. The method enables the rapid and precise characterisation of bacteria.<br />

    Measurement instead of culture – rapid detection of Legionella

    There has been an unusually high frequency of Legionella infections in the city of Ulm in the period since mid-December 2009. The search for the source of the infection is well underway, although the use of traditional detection methods make it a time-consuming process. New screening methods developed by the Fraunhofer IPM could considerably reduce the time required to detect the source of infection.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/measurement-instead-of-culture-rapid-detection-of-legionella
  • Article - 29/07/2011 14959_de.jpg

    Labor Dr. Merk und Kollegen - Viruses under control

    It is difficult to imagine how Ochsenhausen-based Labor Dr. Merk und Kollegen (LMK) would be able to develop, produce and test medical products for bacterial and viral contaminations without using cell cultures. The medium-sized company also produces viruses for testing and has stored more than 80 different viruses – enveloped and non-enveloped ones, animal and human pathogens – at -80˚C.

    https://www.gesundheitsindustrie-bw.de/en/article/news/labor-dr-merk-und-kollegen-viruses-under-control
  • Press release - 28/05/2009 08708_de.jpg

    CONCERT Medical Optics wins special CyberOne prize

    The company CONCERT Medical Optics was selected from more than 70 participants from all over Germany to receive a special CyberOne prize for the most innovative start-up concept namely a medical instrument called EndoTherapeuthoSkop. This instrument combines different technologies enabling the simultaneous detection and treatment of tumours meaning that patients only have to undergo one rather than several interventions.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/concert-medical-optics-wins-special-cyberone-prize
  • Article - 12/08/2013 20164_de.jpg

    Sensovation AG: a special camera for rapid allergy diagnosis

    Between 20 and 30 million Germans suffer from allergies to house dust mites, pollen and many other allergens¹. The diagnosis of allergies is usually a rather time-consuming process as more than 20,000 potential allergens need to be tested in order to identify the allergen that causes a patient’s particular symptoms². Sensovation AG has developed a technology that allows the parallel analysis of 20 allergens and which has the potential to simplify…

    https://www.gesundheitsindustrie-bw.de/en/article/news/sensovation-ag-a-special-camera-for-rapid-allergy-diagnosis
  • Press release - 19/12/2011 16030_de.jpg

    cetics healthcare - Metabolomic snapshot – one drop blood is enough

    Newly founded Esslingen-based cetics healthcare technologies is developing a new platform that combines innovative analysis technologies for medical diagnostics. By linking biological testing methods with spectroscopic detection technology and automation, information on all key blood values and existing medical conditions can be delivered in just one single measurement.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/cetics-healthcare-metabolomic-snapshot-one-drop-blood-is-enough
  • Press release - 06/07/2012 Money

    Medicyte is receiving 4.2 Mio Euros from the European Union Seventh Framework Programm

    Medicyte, The Electrospinning Company and the Universities of Manchester and Pisa launch a European wide unique project with the aim to design a biomimetic bioartificial liver (Re-Liver). The company GABO:mi ensures professional project management. Research is receiving 4.2 Mio Euros from the European Union Seventh Framework Programme.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/medicyte-is-receiving-4-2-mio-euros-from-the-european-union-seventh-framework-programm
  • Article - 10/05/2008 Prof. Dr. Michael Laniado (right) and Prof. Dr. Dierk Vorwerk (left) awarded the Wilhelm-Conrad-Röntgen Prize to Prof. Dr. Martin Bendszus (centre).

    Wilhelm Conrad Röntgen Prize 2008

    Prof. Dr. Martin Bendszus was awarded the Wilhelm Conrad Röntgen Prize 2008. He received the prize together with 10000 euros for his work dealing with in vivo diagnostics of the peripheral nervous system using magnetic resonance imaging.

    https://www.gesundheitsindustrie-bw.de/en/article/news/wilhelm-conrad-roentgen-prize-2008
  • Article - 12/08/2009 09312_de.jpg

    More effective extraction of small RNAs

    Small RNAs are gaining in importance in research as well as in the biotechnology and pharmaceutical industries. However the potential of these molecules can only be exploited fully if very pure RNAs can be extracted from the cells in sufficiently high quantities. Currently used methods are expensive and only designed for large cell quantities. In addition the operation of the extraction systems is very complicated. A new biochip developed by Dr.…

    https://www.gesundheitsindustrie-bw.de/en/article/news/more-effective-extraction-of-small-rnas
  • Diagnostics - 29/01/2018 The schematic shows a continuum of lipoprotein particles or different size and their division into major classes and subclasses.

    New test for extended blood fat analysis

    Cholesterol is seen as the cause of atherosclerosis, a disease that can lead to heart attacks and strokes. However, it now seems that the way cholesterol is packaged may be even more important than high blood cholesterol levels. Nuclear magnetic resonance (NMR) spectroscopy now allows the high-throughput analysis of such lipid packages.

    https://www.gesundheitsindustrie-bw.de/en/article/news/new-test-for-extended-blood-fat-analysis
  • Press release - 29/03/2012 12629_de.jpg

    GATC Biotech’s NightXpress sequencing service goes Europe-wide

    GATC Biotech, Europe’s leading sequencing provider, now offers its overnight sequencing service NightXpress Europe wide. This unique overnight service has been made possible by the recently opened European Custom Sequencing Centre in Cologne. In Constance, the company’s headquarters, GATC Biotech is building up the European Genome and Diagnostics Centre.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/gatc-biotech-s-nightxpress-sequencing-service-goes-europe-wide
  • Medical technology - 14/03/2016 Experimenteller_Interventionsraum_mit_mobilen_Rontgengerat_Monitoren_und_OP-Tisch_an_dem_der_Interventionsassistent_herangefahren_werden_kann.jpg

    The operating room of the future: minimally invasive and future-oriented intervention techniques

    Being able to diagnose and treat tumour patients in just a few hours is just one of the many promising goals of the Fraunhofer Project Group for Automation in Medicine and Biotechnology (PAMB). The overall goal of the Intervention and Therapy research group is to take innovative technologies for diagnostic and therapeutic interventions from laboratory development to prototype production for use in clinical trials.

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-operating-room-of-the-future-minimally-invasive-and-future-oriented-intervention-techniques
  • Article - 03/09/2009 09549_de.jpg

    Company establishment with combined forces

    The company DSL a specialist in molecular diagnostics is currently being established in the city of Eriskirch close to Friedrichshafen Germany. The future managing directors Dr. Sabine Lautenschläger and Dr. Daniel Schaarschmidt are being supported by the BioLAGO network and the pharmaceutical company Nycomed.

    https://www.gesundheitsindustrie-bw.de/en/article/news/company-establishment-with-combined-forces
  • Article - 12/08/2013 20169_de.jpg

    A complete exome sequence in one week

    The exome is the part of the genome that is formed by exons i.e. the DNA regions that code for proteins and other functional products. Though comprising only about 1 of the total genome the majority of disease-causing mutations occur in the exome. Selectively sequencing the coding regions of the genome is quicker than whole-genome sequencing. Therefore exome sequencing plays an important role in the diagnosis of genetic diseases and cancer.…

    https://www.gesundheitsindustrie-bw.de/en/article/news/a-complete-exome-sequence-in-one-week
  • Press release - 03/12/2018

    SpinDiag closes second financing round of EUR 3.0 million (USD 3.4 million) to complete product development of its point-of-care screening system for antibiotic-resistant bacteria

    One year after its seed financing, SpinDiag GmbH closes a second financing round of EUR 3 million (USD 3.4 million) as planned. The financing will enable SpinDiag to complete the product development of its first product for screening for antibiotic-resistant bacteria and to start clinical trials. This will pave the way for regulatory approval in the EU.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/spindiag-closes-second-financing-round-of-eur-30-million-usd-34-million-to-complete-product-development-of-its-point-of-care-scr
  • Press release - 28/07/2009 09168_de.jpg

    Fostering enthusiasm for successful entrepreneurship

    BioRegio STERN Management GmbH has honoured the winning projects in the regional “Science2Start” competition. A panel of experts awarded a total of 2,250 euros for the most innovative ideas with marketing potential. The winners celebrated their success with approx. 240 visitors of the annual summer event jointly organised by BioRegio STERN Management GmbH, the Society for the Promotion of Biotechnology Stuttgart/Tübingen/Neckar-Alb e.V. and PUSH!…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/fostering-enthusiasm-for-successful-entrepreneurship
  • Press release - 17/12/2012 15740_de.jpg

    Curetis AG initiates clinical trial in the U.S. towards FDA clearance

    Curetis AG announced the start of a clinical trial of its Unyvero™ System and the corresponding LRT (lower respiratory tract) application in the U.S. The company expects enrollment completion within the next 12-15 months, followed by a 510(k) submission to the FDA in 2014. The prospective, multicenter trial will include samples collected from more than 2,000 hospitalized patients suspected to have a lower respiratory tract infection and several…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/curetis-ag-initiates-clinical-trial-in-the-u-s-towards-fda-clearance
  • Press release - 20/10/2008

    Ultra fast magnetic resonance imaging

    The European Research Council is to fund a project at the University Hospital of Freiburg on the development of ultra fast magnetic resonance imaging for applications in the fields of neurology the neurosciences and oncology.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/ultra-fast-magnetic-resonance-imaging
  • Dossier - 03/07/2008 Normal blood flow in the aorta. MRI also reveals pathological changes and enables the early prognosis of cardiovascular diseases.

    Molecular imaging - a close look inside the human body

    Molecular imaging recognises the functional state of cells and molecules. It visualises biological processes on the cellular and molecular level and is thus able to detect pathological alterations a long time before disease symptoms become apparent. Molecular imaging offers new possibilities for improving diagnosis and enabling more targeted therapies than has previously been possible. Many experts regard molecular imaging as a paradigm shift in…

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/molecular-imaging-a-close-look-inside-the-human-body

Page 5 / 17

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 17
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2022
Website address: https://www.gesundheitsindustrie-bw.de/en/search